Ultivue, Inc. — Form D/A
Ultivue, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-02-01. The offering totals $20.5M, of which $20.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-01
- Form: D/A
- Accession: 0001651511-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.5M
- Amount sold: $20.2M
- Remaining: $250K
- Investors: 11
- Date of first sale: 2017-07-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291239
Issuer
- Name: Ultivue, Inc.
- CIK: 0001651511
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 763D CONCORD AVE., CAMBRIDGE, MA, 02138
- Phone: 877-858-4883
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Andrea Jackson | Director | Marlborough, MA |
| Keith Crandell | Director | Sunnyvale, CA |
| Robert Carson | Director | Waltham, MA |
| Robert Carson | Executive Officer | Waltham, MA |
| Fenel Eloi | Director | Woburn, MA |
| Peng Yin | Director | Woburn, MA |
| Michael Natan | Director | CAMBRIDGE, MA |
| Michael Natan | Executive Officer | CAMBRIDGE, MA |
| David R Walt | Director | Billerica, MA |
| David R Walt | Executive Officer | Billerica, MA |
| Lian Yong Chen | Director | Cambridge, MA |
| Wen R Chen | Director | Cambridge, MA |
| Sharon Yong Kedar | Director | Cambridge, MA |
| Andrew Stevenson | Director | Cambridge, MA |
| Peng R Ying | Director | Cambridge, MA |
| Peng R Ying | Executive Officer | Cambridge, MA |
Other filings by this issuer (4)
More